142 related articles for article (PubMed ID: 16610807)
1. Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.
Ramos-Lima FJ; Vrána O; Quiroga AG; Navarro-Ranninger C; Halámiková A; Rybnícková H; Hejmalová L; Brabec V
J Med Chem; 2006 Apr; 49(8):2640-51. PubMed ID: 16610807
[TBL] [Abstract][Full Text] [Related]
2. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
3. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
Najajreh Y; Kasparkova J; Marini V; Gibson D; Brabec V
J Biol Inorg Chem; 2005 Nov; 10(7):722-31. PubMed ID: 16208494
[TBL] [Abstract][Full Text] [Related]
5. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
[TBL] [Abstract][Full Text] [Related]
6. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
Prokop R; Kasparkova J; Novakova O; Marini V; Pizarro AM; Navarro-Ranninger C; Brabec V
Biochem Pharmacol; 2004 Mar; 67(6):1097-109. PubMed ID: 15006546
[TBL] [Abstract][Full Text] [Related]
7. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
8. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
[TBL] [Abstract][Full Text] [Related]
9. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J
Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573
[TBL] [Abstract][Full Text] [Related]
10. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
Zaludová R; Natile G; Brabec V
Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661
[TBL] [Abstract][Full Text] [Related]
11. Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex.
Stehlíková K; Kaspárková J; Nováková O; Martínez A; Moreno V; Brabec V
FEBS J; 2006 Jan; 273(2):301-14. PubMed ID: 16403018
[TBL] [Abstract][Full Text] [Related]
12. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
13. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
[TBL] [Abstract][Full Text] [Related]
14. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
[TBL] [Abstract][Full Text] [Related]
15. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
16. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
17. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.
Halámiková A; Heringová P; Kaspárková J; Intini FP; Natile G; Nemirovski A; Gibson D; Brabec V
J Inorg Biochem; 2008; 102(5-6):1077-89. PubMed ID: 18237783
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, crystal structures, DNA binding and cytotoxicity of two novel platinum(II) complexes containing 2-(hydroxymethyl)pyridine and pyridine-2-carboxylate ligands.
Icsel C; Yilmaz VT; Golcu A; Ulukaya E; Buyukgungor O
Bioorg Med Chem Lett; 2013 Apr; 23(7):2117-22. PubMed ID: 23434229
[TBL] [Abstract][Full Text] [Related]
20. Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
Marverti G; Cusumano M; Ligabue A; Di Pietro ML; Vainiglia PA; Ferrari A; Bergomi M; Moruzzi MS; Frassineti C
J Inorg Biochem; 2008 Apr; 102(4):699-712. PubMed ID: 18082268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]